Jaettu ääni

The lecture will further address a range of AI applications in drug discovery, with particular emphasis on structure-based virtual screening and the identification of promising drug candidates. In addition, Dr. Elmasry will present advances in AI-driven de novo drug design, demonstrating how novel compounds can be generated through computational approaches.